WSI24-68-Case-4

From MGH Learn Pathology
WSI24-68-Case-4
41 y.o. female with breast cancer on pembrolizumab.
Immune checkpoint inhibitor therapy effect (increased intraepithelial lymphocytes)
May 6, 2024 3:30:00 PM






Retrieved from "https://learn.mghpathology.org/index.php?title=WSI24-68-Case-4&oldid=134593"
  • Powered by MediaWiki
  • Search Powered by Cargo
  • Massachusetts General Hospital